Selected cell delivery for heart failure

Patent Number: 7097833

This patent is relevant for parties seeking to induce regeneration of cardiac tissue, or other tissue. Although the specification teaches the use of a variety of various peripheral blood and bone marrow stem cell sources for implantation into diseased, damaged, or otherwise subfunctional cardiac tissue, the issued claims only appear to cover the use of autologous, naturally residing cardiac stem cells. The patent has 6 independent issued claims. The first covers autologous lineage negative cells from cardiac muscle for treatment of ischemic tissue, the second covers side population cells from the same source for treatment of ischemic tissue, the third covers autologous lineage negative cells from cardiac muscle for regenerating tissue, the fourth covers autologous side population cells from the same source for regenerating tissue, the fifth covers autologous lineage negative cells from cardiac muscle for treating diseased tissue, and the sixth covers autologous side population cells from the same source for treating diseased tissue.

View this patent on the USPTO website.